Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy. | PLoS Biol | 2023 | 37531320 | PubTator, text mining | PubMed |
| Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study. | Life (Basel) | 2023 | 37511907 | PubTator, text mining | PubMed |
| SDC2 Stabilization by USP14 Promotes Gastric Cancer Progression through Co-option of PDK1. | Int J Biol Sci | 2023 | 37496999 | PubTator, text mining | PubMed |
| Metabolism, metabolites, and macrophages in cancer. | J Hematol Oncol | 2023 | 37491279 | PubTator, text mining | PubMed |
| Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib. | Front Pharmacol | 2023 | 37475713 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics. | Front Mol Biosci | 2023 | 37469704 | PubTator, text mining | PubMed |
| PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells. | Mol Oncol | 2023 | 37458534 | PubTator, text mining | PubMed |
| How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication? | Cancer Drug Resist | 2023 | 37457126 | PubTator, text mining | PubMed |
| Network pharmacology, molecular docking and experimental verification help unravel chelerythrine's potential mechanism in the treatment of gastric cancer. | Heliyon | 2023 | 37449157 | PubTator, text mining | PubMed |
| MicroRNAs in Tumor Endothelial Cells: Regulation, Function and Therapeutic Applications. | Cells | 2023 | 37443725 | PubTator, text mining | PubMed |
| Prediction of Distant Metastases in Patients with Kidney Cancer Based on Gene Expression and Methylation Analysis. | Diagnostics (Basel) | 2023 | 37443682 | PubTator, text mining | PubMed |
| Whole-genome transcriptome and DNA methylation dynamics of pre-implantation embryos reveal progression of embryonic genome activation in buffaloes. | J Anim Sci Biotechnol | 2023 | 37430306 | PubTator, text mining | PubMed |
| Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy. | Front Cell Dev Biol | 2023 | 37427373 | PubTator, text mining | PubMed |
| The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications. | Exp Hematol Oncol | 2023 | 37415251 | PubTator, text mining | PubMed |
| Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma. | Int J Mol Sci | 2023 | 37373523 | PubTator, text mining | PubMed |
| Epigenetic Changes Associated with Osteosarcoma: A Comprehensive Review. | Cells | 2023 | 37371065 | PubTator, text mining | PubMed |
| Analysis of age-dependent gene-expression in human tissues for studying diabetes comorbidities. | Sci Rep | 2023 | 37365269 | PubTator, text mining | PubMed |
| Micro-engineering and nano-engineering approaches to investigate tumour ecosystems. | Nat Rev Cancer | 2023 | 37353679 | PubTator, text mining | PubMed |
Inflammasome activation and metabolic remodelling in p16-positive aging cells aggravates high-fat diet-induced lung fibrosis by inhibiting NEDD4L-mediated K48-polyubiquitin-dependent degradation of SGK1. | Clin Transl Med | 2023 | 37345264 | PubTator, text mining | PubMed |
| Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics. | Nat Commun | 2023 | 37328470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers?page=10